NCT02720419进行中（未招募）不适用
Evaluation of Effectiveness and Safety of Synergy™ Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Jung-min Ahn28 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2016年8月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 3,000
- 试验地点
- 28
- 主要终点
- Composite event
研究概览
简要总结
The purpose of this study is to evaluate the relative effectiveness and safety of Synergy stent compared to other drug eluting stents.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 19 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 19 and more
- •Intervention with Synergy stent
- •Agreed with written informed consent form
排除标准
- •Intervention with Synergy stent and other drug eluting stent at the same time
- •Life expectancy of 1year and under
- •Cardiac shock
结局指标
主要结局
Composite event
时间窗: 1 year
The number of events with the first occurrence of a composite event(death, non-fatal myocardial infarction, target vessel revascularization)
次要结局
- Stroke(5 years)
- Procedural success(3 days)
- All death(5 years)
- Composite event of death or myocardial infarction(5 years)
- Cardiac death(5 years)
- Myocardial infarction(5 years)
- Composite event of cardiac death or myocardial infarction(5 years)
- Target lesion revascularization(5 years)
- Target vessel revascularization(5 years)
- Stent thrombosis(5 years)
研究者
Jung-min Ahn
assistant professor
Asan Medical Center
研究点 (28)
Loading locations...
相似试验
招募中
不适用
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ StentCoronary Artery DiseaseCardiovascular DiseasesHeart DiseasesCoronary DiseaseMyocardial IschemiaNCT05044273Jung-min Ahn2,000
尚未招募
不适用
Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock PatientsExtracorporeal Membrane OxygenationECLSVA ECMOCardiogenic ShockNCT05106491Xenios AG21
进行中（未招募）
不适用
IRIS-Onyx Cohort in the IRIS-DES RegistryArterial Occlusive DiseasesCardiovascular DiseasesPercutaneous Transluminal AngioplastyCoronary Artery DiseaseNCT02593994Seung-Jung Park4,500
Unknown
不适用
Consistent CTO TrialChronic Total OcclusionNCT02227771European Cardiovascular Research Center215
已完成
2 期
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2Malignant MelanomaNCT01480323University Hospital Tuebingen15